| Literature DB >> 28774058 |
Cijun Shuai1,2, Chenying Shuai3, Ping Wu4, Fulai Yuan5, Pei Feng6, Youwen Yang7,8, Wang Guo9, Xiaohan Fan10, Ting Su11, Shuping Peng12,13,14, Chengde Gao15.
Abstract
Bioactivity and biocompatibility are crucial for tissue engineering scaffolds. In this study, hydroxyapatite (HAP) was incorporated into polyetheretherketone/polyglycolicacid (PEEK/PGA) hybrid to improve its biological properties, and the composite scaffolds were developed via selective laser sintering (SLS). The effects of HAP on physical and chemical properties of the composite scaffolds were investigated. The results demonstrated that HAP particles were distributed evenly in PEEK/PGA matrix when its content was no more than 10 wt %. Furthermore, the apatite-forming ability became better with increasing HAP content after immersing in simulated body fluid (SBF). Meanwhile, the composite scaffolds presented a greater degree of cell attachment and proliferation than PEEK/PGA scaffolds. These results highlighted the potential of (PEEK/PGA)-HAP scaffolds for tissue regeneration.Entities:
Keywords: Hydroxyapatite; bioactivity; biocompatibility; composite scaffolds; selective laser sintering
Year: 2016 PMID: 28774058 PMCID: PMC5457255 DOI: 10.3390/ma9110934
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1(a) Top view; (b) isometric view; and (c) lateral view of the polyetheretherketone/ polyglycolicacid-hydroxyapatite (PEEK/PGA-HAP) composite scaffold.
Figure 2Morphologies of the scaffolds with (a) 0 wt %; (b) 5 wt %; (c) 7.5 wt %; (d) 10 wt %; (e) 12.5 wt %; (f) 15 wt % HAP.
Figure 3X-ray diffraction (XRD) patterns of (a) the HAP powder; (b) the PEEK/PGA scaffold; (c) the PEEK/PGA-5 wt % HAP scaffold; (d) the PEEK/PGA-7.5 wt % HAP scaffold; (e) the PEEK/PGA-10 wt % HAP scaffold; (f) the PEEK/PGA-12.5 wt % HAP scaffold and (g) the PEEK/PGA-15 wt %.
Figure 4Differential scanning calorimetry (DSC) spectra of PEEK/PGA scaffold and PEEK/PGA-HAP composite scaffolds.
Figure 5Elastic modulus, compressive strength and tensile strength of the scaffolds with different HAP contents.
Figure 6Morphologies of the scaffolds with (a) 0 wt %; (b) 5 wt %; (c) 7.5 wt %; (d) 10 wt %; (e) 12.5 wt %; (f) 15 wt % HAP after immersion in simulated body fluid (SBF) for 14 days.
Figure 7Fourier transform infrared spectrums of the scaffolds with 10 wt % HAP before and after immersing in SBF.
Figure 8(a) pH value of the PEEK/PGA scaffold and PEEK/PGA-10 wt % HAP scaffold during in vitro degradation; (b) weight loss of the PEEK/PGA scaffold and PEEK/PGA-10 wt % HAP scaffold after immersing in PBS.
Figure 9MTT assay of MG-63 cells cultured on PEEK/PGA scaffolds and PEEK/PGA-10 wt % HAP scaffolds (* p < 0.05).
Figure 10Fluorescence images of MG63 cells cultured on PEEK/PGA and PEEK/PGA-10 wt % HAP scaffolds for different periods (letters A and B correspond to the two scaffolds. Subscripts indicate the time).
Figure 11Alkaline phosphatase (ALP) activity of MG63 cells cultured on PEEK/PGA scaffolds and PEEK/PGA-10 wt % HAP scaffolds at various time points (* p < 0.05).
Ion concentration in SBF and human blood plasma.
| Ion Type | Ion Concentration (mM) | ||||||
|---|---|---|---|---|---|---|---|
| Na+ | K+ | Mg2+ | Ca2+ | Cl− | |||
| Simulated Body fluid | 142.0 | 5.0 | 1.5 | 2.5 | 148.8 | 4.2 | 1.0 |
| Human blood plasma | 142.0 | 5.0 | 1.5 | 2.5 | 103.0 | 17.0 | 1.0 |